Extracellular matrix in human diabetic nephropathy: reduced expression of heparan sulphate in skin basement membrane

[1]  H. Yokoyama,et al.  Immunohistochemical Quantification of Heparan Sulfate Proteoglycan and Collagen IV in Skeletal Muscle Capillary Basement Membranes of Patients With Diabetic Nephropathy , 1997, Diabetes.

[2]  R. Trevisan,et al.  Enhanced collagen synthesis in cultured skin fibroblasts from insulin-dependent diabetic patients with nephropathy. , 1997, Journal of the American Society of Nephrology : JASN.

[3]  P. Geelhoed-Duijvestijn,et al.  Danaparoid sodium lowers proteinuria in diabetic nephropathy. , 1997, Journal of the American Society of Nephrology : JASN.

[4]  M. Daha,et al.  Differential effects of angiotensin II and transforming growth factor beta on the production of heparan sulfate proteoglycan by mesangial cells in vitro. , 1996, Journal of the American Society of Nephrology : JASN.

[5]  M. Daha,et al.  Effects of high glucose on the production of heparan sulfate proteoglycan by mesangial and epithelial cells. , 1996, Kidney international.

[6]  J. van den Born,et al.  Presence of N-Unsubstituted Glucosamine Units in Native Heparan Sulfate Revealed by a Monoclonal Antibody (*) , 1995, The Journal of Biological Chemistry.

[7]  A. Kofoed-Enevoldsen,et al.  Heparan sulphate in the pathogenesis of diabetic nephropathy. , 1995, Diabetes/metabolism reviews.

[8]  L. L. Moore,et al.  Formation of Immunochemical Advanced Glycosylation End Products Precedes and Correlates With Early Manifestations of Renal and Retinal Disease in Diabetes , 1995, Diabetes.

[9]  R. Bucala,et al.  Immunohistochemical detection of advanced glycosylation end products within the vascular lesions and glomeruli in diabetic nephropathy. , 1995, Human pathology.

[10]  B. Feldt-Rasmussen,et al.  Effect of low-dose heparin on urinary albumin excretion in insulin-dependent diabetes mellitus , 1995, The Lancet.

[11]  G. Gambaro,et al.  Treatment with a glycosaminoglycan formulation ameliorates experimental diabetic nephropathy. , 1994, Kidney international.

[12]  J. van den Born,et al.  Monoclonal antibodies against the protein core and glycosaminoglycan side chain of glomerular basement membrane heparan sulfate proteoglycan: characterization and immunohistological application in human tissues. , 1994, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[13]  J. Bruijn,et al.  Distinct patterns of expression of intercellular adhesion molecule-1, vascular cell adhesion molecule-1, and endothelial-leukocyte adhesion molecule-1 in renal disease. , 1993, Laboratory investigation; a journal of technical methods and pathology.

[14]  J. van den Born,et al.  Distribution of GBM heparan sulfate proteoglycan core protein and side chains in human glomerular diseases. , 1993, Kidney international.

[15]  G. Gambaro,et al.  Glycosaminoglycans prevent morphological renal alterations and albuminuria in diabetic rats. , 1992, Kidney international.

[16]  R. Bucala,et al.  Immunochemical detection of advanced glycosylation end products in vivo. , 1992, The Journal of biological chemistry.

[17]  N. Kashihara,et al.  Current status of the structural and functional basis of glomerular filtration and proteinuria. , 1991, Seminars in nephrology.

[18]  J. van den Born,et al.  Isolation and partial characterization of heparan sulphate proteoglycan from the human glomerular basement membrane. , 1989, The Biochemical journal.

[19]  C. Bombardier,et al.  Pathologic features of diabetic thick skin. , 1987, Journal of the American Academy of Dermatology.

[20]  T. Shigematsu,et al.  Immunohistochemical detection of advanced glycosylation end-products in the peritoneum and its possible pathophysiological role in CAPD. , 1997, Kidney international.

[21]  J. van den Born,et al.  Is microalbuminuria in diabetes due to changes in glomerular heparan sulphate? , 1995, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[22]  H. Parving.  The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. , 1994, The New England journal of medicine.

[23]  A Fournier,et al.  The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. , 1994, The New England journal of medicine.

[24]  J. van den Born,et al.  A monoclonal antibody against GBM heparan sulfate induces an acute selective proteinuria in rats. , 1992, Kidney international.

[25]  R. Butkowski,et al.  Characterization of monoclonal antibodies to the globular domain of collagen IV. , 1991, Connective tissue research.